PDE4D Inhibitors: Opening a New Era of PET Diagnostics for Alzheimer's Disease
L Shi, X Wang, H Si, W Song - Neurochemistry International, 2024 - Elsevier
As the incidence of Alzheimer's disease (AD) continues to rise, the need for an effective PET
radiotracer to facilitate early diagnosis has become more pressing than ever before in …
radiotracer to facilitate early diagnosis has become more pressing than ever before in …
Kaixinsan regulates neuronal mitochondrial homeostasis to improve the cognitive function of Alzheimer's disease by activating CaMKKβ-AMPK-PGC-1α signaling axis
J Ren, B Xiang, L Song, DJ René, Y Luo, G Wen, H Gu… - Phytomedicine, 2024 - Elsevier
Background Alzheimer's disease (AD) is a neurodegenerative disease primarily
characterized by cognitive impairments. With the intensification of population aging, AD has …
characterized by cognitive impairments. With the intensification of population aging, AD has …
[HTML][HTML] Role of IGF1/IGFR signaling pathway in neuroprotective effect of Shengmai Dihuang Decoction on CIH-induced cognitive impairment
X Chen, K Qi, J Si, D Li, X Fan, M Sun, S Yang… - Journal of Traditional and …, 2024 - Elsevier
Background As the most important pathophysiological process of obstructive sleep apnea
(OSA), chronic intermittent hypoxia (CIH) could cause cognitive impairment. Our previous …
(OSA), chronic intermittent hypoxia (CIH) could cause cognitive impairment. Our previous …